A novel G-quadruplex-forming GGA repeat region in the c-myb promoter is a critical regulator of promoter activity
SunMi L. Palumbo(University of Arizona), Scot Ebbinghaus(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yulia Krotova-Khan(University of Arizona), Diana Uribe(University of Arizona), Laurence H. Hurley(University of Arizona), Regan M. Memmott(The Ohio State University)
Cited by 186
Related Papers
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
|New England Journal of Medicine|2013|3.4k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k